ANASTROZOLE
- Product NDC
- 42291-016
- 11-digit product format
- 422910016
- Labeler code
- 42291
- Product ID
- 42291-016_48481e73-92ad-d506-e063-6394a90a6518
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ANASTROZOLE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- AvKARE
- Application
- ANDA079220
- Marketing category
- ANDA
- Marketing start
- 2023-02-06
- Substance
- ANASTROZOLE
- Active strength
- 1 mg/1
- Pharmacologic classes
- Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ANASTROZOLE
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ANASTROZOLE | 1 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 2Z07MYW1AZ |
| Rxcui | 199224 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 42291-016-30 | ANASTROZOLE | 30 in 1 BOTTLE | TABLET | 30 | | 2 |
| 42291-016-90 | ANASTROZOLE | 90 in 1 BOTTLE | TABLET | 90 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 42291-016 | ANASTROZOLE TABLET [AVKARE] | 1 | Current NDC, 2 package rows | 20230207_f40b925f-9f43-321d-e053-2a95a90aca8b.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 42291-016-30 | 42291001630 | 30 TABLET in 1 BOTTLE (42291-016-30) | 30 tablet | 2023-02-06 | No | No | Current |
| 42291-016-90 | 42291001690 | 90 TABLET in 1 BOTTLE (42291-016-90) | 90 tablet | 2023-02-06 | No | No | Current |